HeartWare: Medtronic's HeartWare can't slip investors class action over failed MVAD trial

A federal judge in New York City last week shot down a bid by Medtronic subsidiary HeartWare to dismiss a class-action lawsuit brought over a failed trial of its MVAD implantable heart pump. Framingham, Mass.-based HeartWare in July 2015 launched a clinical trial aimed at winning CE Mark approval in the European Union for the next-generation [...]The post Medtronic's HeartWare can't slip investors class action over failed MVAD trial appeared first on MassDevice.